These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28073228)

  • 61. Lipid Management in Diabetes with a Focus on Emerging Therapies.
    Hoe E; Hegele RA
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S183-90. PubMed ID: 26653256
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Statin induced myotoxicity.
    Sathasivam S
    Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Reduced synthesis of coenzyme Q10 may cause statin related myopathy].
    Nielsen ML; Pareek M; Henriksen JE
    Ugeskr Laeger; 2011 Nov; 173(46):2943-8. PubMed ID: 22094213
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Statin intolerance and associated muscular dysfunctions].
    Boulanger-Piette A; Bergeron J; Desgreniers J; Côté-Levesque M; Brassard D; Joanisse DR; Frenette J
    Med Sci (Paris); 2015 Dec; 31(12):1109-14. PubMed ID: 26672664
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.
    Abdelbaset M; Safar MM; Mahmoud SS; Negm SA; Agha AM
    Can J Physiol Pharmacol; 2014 Jun; 92(6):481-9. PubMed ID: 24896301
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.
    Mancini GB; Tashakkor AY; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng DS; Pearson GJ; Pope J
    Can J Cardiol; 2013 Dec; 29(12):1553-68. PubMed ID: 24267801
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Statins and the neuromuscular system: a neurologist's perspective.
    Argov Z
    Eur J Neurol; 2015 Jan; 22(1):31-6. PubMed ID: 25495398
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intermittent nondaily dosing strategies in patients with previous statin-induced myopathy.
    Keating AJ; Campbell KB; Guyton JR
    Ann Pharmacother; 2013 Mar; 47(3):398-404. PubMed ID: 23482733
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Statin-induced dermatomyositis for the practicing dermatologist: a review of the literature.
    Visconti MJ; Bashyam AM; Jorizzo JL
    Int J Dermatol; 2020 Mar; 59(3):383-387. PubMed ID: 31840246
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Should I take coenzyme Q10 with a statin?
    Williams L; Bradford J
    JAAPA; 2006 Dec; 19(12):61-2. PubMed ID: 17243263
    [No Abstract]   [Full Text] [Related]  

  • 72. Statins Neuromuscular Adverse Effects.
    Attardo S; Musumeci O; Velardo D; Toscano A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955495
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Observations from a statin myopathy clinic.
    Phillips PS; Haas RH
    Arch Intern Med; 2006 Jun; 166(11):1232-3; author reply 1233. PubMed ID: 16772252
    [No Abstract]   [Full Text] [Related]  

  • 74. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The combinations of statins and fibrates: pharmacokinetic and clinical implications].
    González Santos P
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():7-11. PubMed ID: 25043540
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].
    Soska V
    Vnitr Lek; 2011 Mar; 57(3):313-6. PubMed ID: 21495414
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Statin myopathy as a metabolic muscle disease.
    Phillips PS; Haas RH
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies.
    Taha DA; De Moor CH; Barrett DA; Gershkovich P
    Transl Res; 2014 Aug; 164(2):85-109. PubMed ID: 24530275
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aches and pains--is your statin to blame. Muscle pain is the most common side effect of cholesterol-lowering statins.
    Harv Heart Lett; 2008 Sep; 19(1):3. PubMed ID: 18946915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.